Abstract
Epilepsy is a significant comorbidity of cerebral palsy, occurring in 35–62% of affected children. It is the leading cause of hospitalization in children with cerebral palsy. Most patients with CP and epilepsy will experience their first seizures within their first year of life. The diagnosis of epilepsy is guided by the clinical scenario and EEG findings, with the assessment of likelihood of seizure recurrence as the most important factor. The choice of anticonvulsant medication is based upon seizure semiology, syndrome, and expected side effects. Specific epileptic syndromes, most notably infantile spasms and Lennox-Gastaut syndrome, are especially prevalent in the cerebral palsy population. Although a serious problem, there is a high likelihood of both seizure control and seizure remission after 3 years of treatment, in the population with cerebral palsy and epilepsy.
Similar content being viewed by others
References
Aaberg KM, Gunnes N, Bakken IJ et al (2017) Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics 139(5):e20163908
Ashwal S, Russman BS, Blasco PA et al (2004) Practice parameter: diagnostic assessment of the child with cerebrla palsy. Neurology 62:851–863
Bruck I, Antoniuk SA, Spessatto A et al (2001) Epilepsy in children with cerebral palsy. Arq Neuropsiquiatr 59(1):35–39
Chugani HT, Ilyas M, Kumar A et al (2015) Surgical treatment for refractory epileptic spasms: the Detroit experience. Epilepsia 56(12):1941–1949
Colver A, Fairhurst C, Pharoah PO (2014) Cerebral palsy. Lancet 363(9924):1240–1249
Cooper MS, Mackay MT, Fahey M et al (2017) Seizures in children with cerebral palsy and white matter injury. Pediatrics 139(3):1–9
Coppola G, Fortunado D, Mainolfi C et al (2012) Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy. Epilepsia 53(12):2172–2177
Devinsky O (2011) Sudden unexpected death in epilepsy. N Engl J Med 365:1801–1811
Devinsky O, Cilio MR, Cross H et al (2014) Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55(6):791–802
Devinsky O, Marsh E, Friedman D et al (2016) Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 15:270–278
Devinsky O, Cross H, Laux L et al (2017) Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 376(21):2011–2020
Devinsky O, Patel AD, Cross JH et al (2018) Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med 387:1888–1897
Fox C, Glass HC, Sidney S et al (2016) Neonatal seizures triple the risk of a remote seizures after perinatal ischemic stroke. Neurology 86:2179–2186
Geffrey AL, Pollack SF, Bruno PL, Thiele EA (2015) Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia 56(8):1246–1251
Golomb MR, Garg BP, Williams LS (2006) Outcomes of children with infantile spasms after perinatal stroke. Pediatr Neurol 34(4):291–295
Hadjipanayis A, Hadjichristodoulou C, Youroukos S (1997) Epilepsy in patients with cerebral palsy. Devel Med Child Neurol 39:659–663
Holst AG, Winkel BG, Risgaard B et al (n.d.) Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study. Epilepsia 54(9):1613–1620
Jasega H (2011) Efficacy of vagus nerve stimulation in patients with cerebral palsy: emerging corroborative evidence. Clinical Neurol Neurosurg 113:603
Jaseja H (2007a) Treatment of interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy: hope for a better outcome in prognosis. Clin Neurol Neurosurg 109:221–224
Jaseja H (2007b) Cerebral palsy: interictal epileptiform discharges and cognitive impairment. Clin Neurol Neurosurg 109:549–552
Kharoshankaya L, Stevenson NJ, Livingstone V et al (2016) Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol 58(12):1242–1248
Kurokawa T, Nagahide G, Fukuyama Y et al (1980) West syndrome and Lennox-Gastaut syndrome: a survey of natural history. Pediatrics 65(1):81–88
Maartens IA, Wassenberg T, Buijs J et al (2012) Neurodevelopmental outcome in full-term newborns with refractory neonatal seizures. Acta Paediatr 101:e173–e178
Novak I, Hines M, Goldsmith S, Barclay R (2012) Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics 130(5):1265–1312
Olsson I, Danielsson S, Hedström A et al (2013) Epilepsy surgery in children with accompanying impairments. Eur J Paediatr Neurol 17(6):645–650
Pera MC, Brazzo D, Altieri N et al (2013) Long-term evolution of neuropsychological competences in encephalopathy with status epilepticus during sleep: a variable prognosis. Epilepsia 54(Suppl 7):77–85
Ronen GM, Buckley D, Penney S, Streiner DL (2007) Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 69(19):1816–1822
Russ SA, Larson K, Halfon N (2012) A national profile of childhood epilepsy and seizure disorder. Pediatrics 129(2):256–264
Scheffer IE, Berkovic S, Capovilla G et al (2017) ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 58(4):512–521
Senbil N, Sonel B, Aydin OF, Gürer YK (2002) Epileptic and non-epileptic cerebral palsy: EEG and cranial imaging findings. Brain Dev 24(3):166–169
Serin HM, Koҫ ZP, Temelli B, Esen I (2015) The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine. Epilepsy Behav 51(10):221–224
Singhi P, Jagirdar S, Khandelwal N, Malhi P (2003) Epilepsy in children with cerebral palsy. J Child Neurology 18(3):174–179
Song JM, Hahn J, Kim SH, Chang MJ (2017) Efficacy of treatments for infantile spasms: a systematic review. Clin Neuropharmacol 40(2):63–84
Stafstrom CE, Arnason BGW, Baram TZ et al (2011) Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol 26(11):1411–1421
Van Rijckevorsel K (2008) Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsych Dis Treat 4(6):1001–1019
Van Rotterdam AB (2011) Biophysical aspects of EEG and magnetoencephalogram generation. In: Schomer DL, Lopes da Silva FH (eds) Neidermeyer’s electroencephalography – basic principles, clinical applications, and related fields, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 102–103
Yeh HR, Kim MJ, Ko TS et al (2017) Short-term outcome of intravenous methylprednisolone pulse therapy in patients with infantile spasms. Pediatr Neurol 71:50–55
Young NL, McCormick AM, Gilbert T et al (2011) Reasons for hospital admissions among youth and young adults with cerebral palsy. Arch Phys Med Rehabil 92:46–50
Zack MM, Kobau R (2017) National and state estimates of the numbers of adults and children with active epilepsy-United States 2015. MMWR 66:821–825
Zafeiriou DI, Kontopoulos EE, Tsikoulas I (1999) Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol 14(5):289–294
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Falchek, S. (2020). Epilepsy in the Child with Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M.E. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-74558-9_29
Download citation
DOI: https://doi.org/10.1007/978-3-319-74558-9_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74557-2
Online ISBN: 978-3-319-74558-9
eBook Packages: MedicineReference Module Medicine